Michael Brines
- Hematology top 0.05%
- Erythropoietin and Anemia Treatment 69
- Genetics top 0.5%
- Nephrology top 0.5%
- Developmental Neuroscience top 1%
- Neurology top 0.5%
- Vagus Nerve Stimulation Research 17
-
- PARP inhibition in cancer therapy 27
-
- Neuroscience and Neuropharmacology Research 17
-
- Erythrocyte Function and Pathophysiology 14
- Pain Mechanisms and Treatments 13
-
- Ion channel regulation and function 14
-
- Pharmacological Effects and Toxicity Studies 9
- Co-authors
- Anthony CeramiPietro GhezziDavide AgnelloNihal C. de LanerolleThomas R. ColemanLoretta M. ItriTiziana MenniniSerhat Erbayraktar
- Cited by
- HematologyGeneticsNephrology
- Journals
- Proceedings of the National Academy of Sciences (24 papers)Molecular Medicine (17 papers)Brain Research (6 papers)
- Partner nations
- United StatesItalyNetherlands
In The Last Decade
Michael Brines
158 papers receiving 12.2k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Hematology 6.2k
- Genetics 1.6k
- Nephrology 963
- Developmental Neuroscience 477
- Neurology 949
Countries citing papers authored by Michael Brines
This map shows the geographic impact of Michael Brines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Brines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Brines more than expected).
Fields of papers citing papers by Michael Brines
This network shows the impact of papers produced by Michael Brines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Brines. The network helps show where Michael Brines may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Brines, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2024 | 7 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 13 | |
| 6 | 2021 | 60 | |
| 7 | ARA290 (cibinetide) treatment confers neuroprotective effects in diabetic retinopathy, through modulation of inflammatory mediators. | 2019 | 1 |
| 8 | 2014 | 31 | |
| 9 | A novel Erythropoietin-derived peptide regulates Endothelial Progenitor Cell (EPC) mediated retinal vasorepair | 2013 | 1 |
| 10 | 2013 | 71 | |
| 11 | 2006 | 101 | |
| 12 | 2006 | 70 | |
| 13 | 2006 | 247 | |
| 14 | Erythropoietin mediates tissue protection through an erythropoietin and common β-subunit heteroreceptorbreakdown → | 2004 | 527 |
| 15 | 2004 | 265 | |
| 16 | 2003 | 430 | |
| 17 | 2002 | 45 | |
| 18 | 2000 | 262 | |
| 19 | 1994 | 0 | |
| 20 | 1992 | 10 |
About Michael Brines
Michael Brines is a scholar working on Hematology, Neurology and Physiology, having authored 160 papers that have together received 12.6k indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (69 papers), PARP inhibition in cancer therapy (27 papers), Vagus Nerve Stimulation Research (17 papers), Neuroscience and Neuropharmacology Research (17 papers), Erythrocyte Function and Pathophysiology (14 papers), Ion channel regulation and function (14 papers), Pain Mechanisms and Treatments (13 papers) and Pharmacological Effects and Toxicity Studies (9 papers). The work is most often cited by research in Hematology (6.2k citations), Genetics (1.6k citations) and Nephrology (963 citations). Michael Brines has collaborated with scholars based in United States, Italy and Netherlands. Frequent co-authors include Anthony Cerami, Pietro Ghezzi, Davide Agnello, Nihal C. de Lanerolle, Thomas R. Coleman, Loretta M. Itri, Tiziana Mennini, Serhat Erbayraktar, Roberto Latini and Pia Villa. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Medicine, Brain Research, Scientific Reports and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.